Simergent is focused on revolutionizing home dialysis through its innovative Archimedes system, which is designed to address the common challenges faced by patients using current peritoneal dialysis (PD) devices. The Archimedes system features patented technology aimed at enhancing patient experience by significantly reducing the risks associated with peritonitis and improving usability. With lower filling and draining pressures compared to existing devices, it ensures accurate volume control while minimizing discomfort. This user-friendly design allows patients to maintain a more active lifestyle, enabling them to socialize and engage in daily activities without being confined to their homes for treatment.

The company emphasizes the importance of patient-centric solutions, as evidenced by a market research study where Archimedes received a remarkable 98% appeal score from current PD patients, far surpassing the 29%-36% scores of competitor devices. Although the Archimedes system is not yet FDA approved and has not undergone studies to validate claims regarding peritonitis rates, Simergent is dedicated to developing a safe, effective, and affordable home dialysis option that prioritizes the needs and well-being of patients.

United States

Simergent is a medical device company that has developed a disruptive Archimedes affordable home dialysis device and disposable tubing set. The company is committed to putting patients' needs first and was founded in 2014 by CEO and Co-Founder, Steve Lindo.

Simergent

Company Details